The paradox of 5-methoxy-N,N-dimethyltryptamine: An indoleamine hallucinogen that induces stimulus control via 5-HT(1A) receptors

Pharmacology Biochemistry and Behavior

Volumn 65, Issue 1, 2000, Pages 75-82

  Winter, J C ^a   Filipink, R A ^a   Timineri, D ^a   Helsley, S E ^a   Rabin, R A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

5 HT(1A); 5 HT(2A); 5 Methoxy N,N dimethyltryptamine; Drug induced stimulus control; Rat

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,5 DIMETHOXY 4 METHYLAMPHETAMINE; 5 METHOXY N,N DIMETHYLTRYPTAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; PIRENPERONE; PSYCHEDELIC AGENT; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; STIMULUS RESPONSE;

2,5-DIMETHOXY-4-METHYLAMPHETAMINE; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HALLUCINOGENS; MALE; METHOXYDIMETHYLTRYPTAMINES; PINDOLOL; PIPERAZINES; PYRIDINES; RATS; RATS, INBRED F344; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1;

ANIMALIA;

EID: 0033970783     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00178-1     Document Type: Article

References (50)

1. 2 agonist DOI. Eur. J. Pharmacol. 161:1989;45-51.
2. Ator N.A. Drug discrimination and drug stimulus generalization with anxiolytics. Drug Dev. Res. 20:1990;189-204.
3. Ator N.A., Griffiths R.R. Asymmetrical cross-generalization in drug discrimination with lorazepam and pentobarbital training conditions. Drug Dev. Res. 16:1989;355-364.
4. Ator N.A., Griffiths R.R. Selectivity in the generalization profile in baboons trained to discriminate lorazepam. Benzodiazepines, barbiturates, and other sedative/anxiolytics J. Pharmacol. Exp. Ther. 282:1997;1442-1457.
5. 1A receptor-mediated spontaneous tail-flicks in the rat. Eur. J. Pharmacol. 191:1990;185-195.
6. Browne R.G., Ho B.T. Role of serotonin in the discriminative stimulus properties of mescaline. Pharmacol. Biochem. Behav. 3:1975;429-435.
7. Colpaert F.C., Niemegeers C.J.E., Janssen P.A.J. A drug discrimination analysis of LSD. In vivo agonist and antagonist effects of purported 5-HT antagonists and of pirenperone, a LSD-antagonist J. Pharmacol. Exp. Ther. 221:1982;206-214.
8. Fiorella D., Palumbo P.A., Rabin R.A., Winter J.C. The time-dependent stimulus effects of 1-[2,5-dimethoxy-4-methylphenyl]-2-aminopropane [[-]-DOM]. Implications for drug-induced stimulus control as a method for the study of hallucinogenic agents Psychopharmacology (Berlin). 119:1995;239-245.
9. 2C receptors in the stimulus effects of hallucinogenic drugs I. Antagonist correlation analysis Psychopharmacology (Berlin). 121:1995;347-356.
10. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 281:1995;81-88.
11. Fozard J.R., Kidd E.J., Neill J., Tricklebank M. Further characterization of the discriminative stimulus induced by 8-OH-DPAT in rats. Br. J. Pharmacol. 88:1986;371P.
12. Gaddum J.H. Serotonin-LSD interaction. Ann. NY Acad. Sci. 66:1957;562-575.
13. 1A agonist 8-OH-DPAT. Pharmacol. Biochem. Behav. 25:1986;135-139.
14. 2 agonists or antagonists? Neuropsychopharmacology. 3:1990;509-517.
15. Glennon R.A., Rosecrans J.A., Young R., Gaines J. Hallucinogens as discriminative stimuli. Generalization of [-]-DOM to a 5-methoxy-N,N-dimethyltryptamine stimulus Life Sci. 24:1979;993-998.
16. Glennon R.A., Rosecrans J.A., Young R. The use of the drug discrimination paradigm for studying hallucinogenic agents. Colpaert F.C., Slangen J.L. Drug discrimination. Applications in CNS pharmacology:1982;69-96 Elsevier, Amsterdam.
17. 2 involvement in the mechanism of action of hallucinogens. Life Sci. 35:1985;2505-2511.
18. 2 antagonists. Eur. J. Pharmacol. 91:1983;189-192.
19. Glennon R.A., Darmani N.A., Martin B.R. Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents. Life Sci. 48:1991;2493-2498.
20. 1A receptor binding sites in brain? Trends Pharmacol. Sci. 12:1986;336-337.
21. 2A component of the ibogaine-induced discriminative stimulus. Pharmacol. Biochem. Behav. 59:1998;419-425.
22. Hirschhorn I.D., Winter J.C. Mescaline and lysergic acid diethylamide [LSD] as discriminative stimuli. Psychopharmacologia. 22:1971;64-71.
23. Hoyer D., Martin G. 5-HT receptor classification and nomenclature. Towards a harmonization with the human genome Neuropharmacology. 36:1997;419-428.
24. 2 recognition sites in rat and pig brain membranes. Eur. J. Pharmacol. 118:1985;13-23.
25. 2A receptors in the primate cerebral cortex. Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites Proc. Natl. Acad. Sci. USA. 95:1998;735-740.
26. 2-antagonists. Drug Dev. Res. 8:1986;133.
27. Kuhn D.M., White F.J., Appel J.B. Discriminative stimulus properties of hallucinogens. Behavioral assay of drug action Lal H. Discriminative stimulus properties of drugs. 1977;137-155 Plenum, New York.
28. 2 receptors. Life Sci. 28:1981;1015-1022.
29. 2 receptors by DOM treatment. Eur. J. Pharmacol. 163:1989;145-149.
30. 2 binding characteristics with phenylalkylamine hallucinogens. Eur. J. Pharmacol. 145:1988;291-297.
31. Palumbo P.A., Winter J.C. The stimulus properties of ibogaine in rats trained with yohimbine, DOM, and LSD. Pharmacol. Biochem. Behav. 43:1992;1221-1226.
32. 1A receptors may play a role in hallucinogenesis J. Pharmacol. Exp. Ther. 269:1994;1160-1165.
33. 3H]spiroperidol Mol. Pharm. 16:1979;687-699.
34. 1C receptor activation by hallucinogenic drugs Psychopharmacology (Berlin). 108:1991;340-346.
35. Schreiber R., Brocco M., Millan M.J. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the atypical antipsychotics, clozapine and risperidone. Eur. J. Pharmacol. 264:1994;99-102.
36. 2C receptors. Pharmacol. Biochem. Behav. 61:1998;323-330.
37. 1A receptors Psychopharmacology (Berlin). 91:1987;25-29.
38. Spencer D.G., Glaser T., Traber J. Serotonin receptor subtypes mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine. Psychopharmacology (Berlin). 93:1987;158-166.
39. Strassman R.J., Qualls C.R., Berg L.M. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biol. Psychiatry. 39:1996;784-795.
40. Terrace H.S. Stimulus control. Hong W.K. Operant behavior. Areas of research and application:1966;271-344 Appleton-Century-Crofts, New York.
41. 2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology (Berlin). 94:1988;213-216.
42. Tricklebank M.D., Forler C., Middlemiss D.N., Fozard J.R. Subtypes of the 5-HT receptor mediating the behavioral responses to 5-methoxy-N,N-dimethyltryptamine in the rat. Eur. J. Pharmacol. 117:1985;15-24.
43. Winter J.C. Blockade of the stimulus properties of mescaline by a serotonergic antagonist. Arch. Int. Pharmacodyn. 214:1975;250-253.
44. Winter J.C. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide. The role of 5-hydroxytryptamine J. Pharmacol. Exp. Ther. 204:1978;416-423.
45. Winter J.C. Drug-induced stimulus control. Blackman D.E., Sanger D.J. Contemporary research in behavioral pharmacology. 1978;209-237 Plenum, New York.
46. Winter J.C. The stimulus properties of p-methoxyamphetamine. A nonessential serotonergic component Pharmacol. Biochem. Behav. 20:1984;201-203.
47. Winter J.C., Rabin R.A. Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus. Pharmacol. Biochem. Behav. 30:1988;617-624.
48. Young R., Glennon R.A., Rosecrans J.A. Discriminative stimulus properties of the hallucinogenic agent DOM. Commun. Psychopharmacol. 4:1980;501-506.
49. Young R., Rosecrans J.A., Glennon R.A. Comparative discriminative stimulus effects of 5-Methoxy-N,N-dimethyltryptamine and LSD. Life Sci. 30:1982;2057-2062.
50. Young R., Rosecrans J.A., Glennon R.A. Behavioral effects of 5-Methoxy-N,N-dimethyltryptamine and dose-dependent antagonism by BC-105. Psychopharmacology (Berlin). 80:1983;156-160.